Register  /  Login      
  1. Home
  2. Pharma Horizon
  3. Pharma Horizon News from Companies

Pharma Horizon News from Companies

10/03/2017
Catalent To Acquire Cook Pharmica For $950 Million
10/02/2017
Bormioli Rocco Pharma Strengthens Service to North American Market with Dedicated Sales Team
10/02/2017
Value Creation in the Pharma Customer–Supplier Relationship: How Do Companies Measure Up?
09/26/2017
DKSH and Clariant sign agreement for next level pharmaceutical packaging solutions in Vietnam
09/26/2017
Smartox Biotechnology announces research collaboration with Xenon Pharmaceuticals Inc. to identify animal venom molecules that selectively modulate ion channels
09/25/2017
CordenPharma inaugurates third development suite for highly potent oral solid dosage
09/25/2017
Supplementary data integrity functions added for the pharmaceutical industry
09/16/2017
Thermo Fisher Scientific Completes Acquisition Of Patheon
09/13/2017
GSK announces phase III results published in NEJM of mepolizumab in patients with eosinophilic COPD at risk of exacerbations
09/13/2017
Novartis’ Cosentyx® sets new benchmark in psoriasis with robust 5-year sustained Phase III efficacy and safety data
09/13/2017
Basilea announces distribution agreement with Cardiome to commercialize antibiotic Zevtera®/Mabelio® (ceftobiprole) in Europe and Israel
09/06/2017
Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice
08/30/2017
FDA Accepts BioMarin’s Pegvaliase Biologics License Application (BLA) and grants priority review designation
08/30/2017
Cellerant Therapeutics, Inc. awarded $6.86M grant from California Institute for Regenerative Medicine to support development of novel antibody-drug conjugate for AML
08/29/2017
Sanofi completes the acquisition of Protein Sciences
08/25/2017
Charles River Laboratories Acquires Brains On-Line

  • Recent Posts